Michigan Medicine announces COVID-19 unit, new paid sick time for employees

Author | Mary Masson

Michigan Medicine has executed the next phase of a comprehensive COVID-19 planning and response program which includes the opening, today, of a 32-bed isolation unit. 

“In this unprecedented time, we have moved forward with the activation of a Regional Infectious Containment Unit (RICU),” said Marschall Runge, MD, CEO of Michigan Medicine and dean of the Medical School. “This unit enhances care and minimizes risk of disease spread, while improving safety of patients on and off the unit, visitors and staff.”

The RICU was built as a negative pressure unit at Michigan Medicine specifically for these kinds of crises. The unit, which is comprised of 32 private, isolation rooms, follows CDC guidelines. In addition, focused locations with similar capabilities are available within the University’s hospitals. All staff caring for these patients are prepared, trained and have the right supplies.

“Because of our preventive efforts, risk of infection remains low for our employees and visitors, even if you work in our hospitals or near the unit where a COVID-19 patient is isolated,“ Runge said.  

Runge also announced the creation of a special paid time off (PTO) bank for employees who are exposed to COVID-19 while on the job.

 “We strongly believe that we need to recognize our physicians, nurses and all of our staff who are caring for patients with COVID-19, So, in addition to regular, paid time-off benefits, we are providing up to an additional 120 hours, special-use PTO bank for employees who need to quarantine as a result of caring for confirmed COVID-19 patients.”  

This is in addition to the 80 hours of special use PTO that the University of Michigan has given to all of its employees for dealing with the crisis, whether time off is needed because they have the virus or need to care for loved ones.

According to Runge, recognizing staff during these challenging times is a top priority of the health system. “Our health care providers are demonstrating their tremendous commitment to the health of their patients. We are so grateful to our entire team for their dedication during these extraordinary circumstances.”

For more about Michigan Medicine's response to the COVID-19 pandemic, including information for our patients, see https://www.uofmhealth.org/covid-19-update

For more about the University of Michigan's response to COVID-19, see https://publicaffairs.vpcomm.umich.edu/2019-novel-coronavirus-covid-19/

For more about the state of Michigan's response, see https://www.michigan.gov/Coronavirus

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Featured News & Stories Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Study Shows Medical Marijuana Use Decreased in States with Legalized Recreational Use
The number of patients using cannabis for medical purposes has increased more than 600 percent since 2016.
Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.
marijuana leaf drawing blue lab note yellow badge upper left corner
Health Lab
Data shows medical marijuana use decreased in states where recreational use became legal 
Data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment
Illustration of hand holding list, with pill bottle in opposite and and small pic of doctor talking to patient
Health Lab
New urine-based test detects high grade prostate cancer, helping men avoid unnecessary biopsies
A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.
News Release
Michigan Medicine part of research group awarded $15 million to study inflammation's impact on heart, brain health
Research teams from Michigan Medicine, Northwestern University and University of Pittsburgh will lead a $15 million project dedicated to studying inflammation’s role in cardiac and brain diseases. The specific work by Michigan Medicine will focus on the driving forces behind inflammatory processes linked to aging and obesity and how to prevent inflammation that could lead to heart failure, dementia and other diseases.
Florescent image of a human ovarian follicle
Health Lab
Spatial atlas of the human ovary with cell-level resolution will bolster reproductive research
New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.